SEC Filings | Jasper Therapeutics, Inc

Filing date	Description	Form	Filing Group	View
June 20, 2023	Report of unscheduled material events or corporate event	8-K	Current Reports	0001213900-23-050029.pdf 0001213900-23-050029.rtf 0001213900-23-050029.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
June 20, 2023	Statement of changes in beneficial ownership of securities	4	3,4,5	0001213900-23-050220.pdf 0001213900-23-050220.rtf 0001213900-23-050220.xls View HTML
June 20, 2023	Initial filing by director officer or owner of more than ten percent.	3	3,4,5	0001213900-23-050219.pdf 0001213900-23-050219.rtf 0001213900-23-050219.xls View HTML
June 13, 2023	Initial filing by director officer or owner of more than ten percent.	3	3,4,5	0001213900-23-048680.pdf 0001213900-23-048680.rtf 0001213900-23-048680.xls View HTML
June 13, 2023	Statement of changes in beneficial ownership of securities	4	3,4,5	0001213900-23-048681.pdf 0001213900-23-048681.rtf 0001213900-23-048681.xls View HTML
June 13, 2023	Statement of changes in beneficial ownership of securities	4	3,4,5	0001213900-23-048683.pdf 0001213900-23-048683.rtf 0001213900-23-048683.xls View HTML
June 13, 2023	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	144	Other	0001213900-23-048688.pdf 0001213900-23-048688.rtf View HTML
June 8, 2023	Report of unscheduled material events or corporate event	8-K	Current Reports	0001213900-23-047446.pdf 0001213900-23-047446.rtf 0001213900-23-047446.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
June 8, 2023	Statement of changes in beneficial ownership of securities	4	3,4,5	0001213900-23-047567.pdf 0001213900-23-047567.rtf 0001213900-23-047567.xls View HTML
June 8, 2023	Statement of changes in beneficial ownership of securities	4	3,4,5	0001213900-23-047568.pdf 0001213900-23-047568.rtf 0001213900-23-047568.xls View HTML

Data provided by Kaleidoscope.